CITN11-02 interim trial results: subcutaneous administration of recombinant human IL-15 (rhIL-15) is associated with expansion of peripheral blood CD56+ NK cells and CD8+ T cells
暂无分享,去创建一个
T. Waldmann | H. Kohrt | H. Wakelee | D. McNeel | Jeffrey S. Miller | S. Fling | C. Morishima | M. Disis | K. Conlon | P. Sondel | S. Creekmore | Minjun C. Apodaca | M. Patel | J. Thompson